Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Med Chem ; 64(6): 2982-3005, 2021 03 25.
Artigo em Inglês | MEDLINE | ID: mdl-33719423

RESUMO

Most therapeutic agents used for treating brain malignancies face hindered transport through the blood-brain barrier (BBB) and poor tissue penetration. To overcome these problems, we developed peptide conjugates of conventional and experimental anticancer agents. SynB3 cell-penetrating peptide derivatives were applied that can cross the BBB. Tuftsin derivatives were used to target the neuropilin-1 transport system for selectivity and better tumor penetration. Moreover, SynB3-tuftsin tandem compounds were synthesized to combine the beneficial properties of these peptides. Most of the conjugates showed high and selective efficacy against glioblastoma cells. SynB3 and tandem derivatives demonstrated superior cellular internalization. The penetration profile of the conjugates was determined on a lipid monolayer and Transwell co-culture system with noncontact HUVEC-U87 monolayers as simple ex vivo and in vitro BBB models. Importantly, in 3D spheroids, daunomycin-peptide conjugates possessed a better tumor penetration ability than daunomycin. These conjugates are promising tools for the delivery systems with tunable features.


Assuntos
Antineoplásicos/farmacocinética , Barreira Hematoencefálica/metabolismo , Neoplasias Encefálicas/tratamento farmacológico , Peptídeos Penetradores de Células/farmacocinética , Glioblastoma/tratamento farmacológico , Oligopeptídeos/farmacocinética , Tuftsina/farmacocinética , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Neoplasias Encefálicas/metabolismo , Linhagem Celular Tumoral , Peptídeos Penetradores de Células/química , Peptídeos Penetradores de Células/farmacologia , Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacologia , Sistemas de Liberação de Medicamentos , Glioblastoma/metabolismo , Células Endoteliais da Veia Umbilical Humana , Humanos , Neuropilina-1/metabolismo , Oligopeptídeos/química , Oligopeptídeos/farmacologia , Ratos , Esferoides Celulares/efeitos dos fármacos , Esferoides Celulares/metabolismo , Tuftsina/análogos & derivados , Tuftsina/farmacologia , Células Tumorais Cultivadas
2.
Int J Mol Sci ; 21(6)2020 Mar 22.
Artigo em Inglês | MEDLINE | ID: mdl-32235796

RESUMO

Cell-penetrating peptides might have great potential for enhancing the therapeutic effect of drug molecules against such dangerous pathogens as Mycobacterium tuberculosis (Mtb), which causes a major health problem worldwide. A set of cationic cell-penetration peptides with various hydrophobicity were selected and synthesized as drug carrier of isoniazid (INH), a first-line antibacterial agent against tuberculosis. Molecular interactions between the peptides and their INH-conjugates with cell-membrane-forming lipid layers composed of DPPC and mycolic acid (a characteristic component of Mtb cell wall) were evaluated, using the Langmuir balance technique. Secondary structure of the INH conjugates was analyzed and compared to that of the native peptides by circular dichroism spectroscopic experiments performed in aqueous and membrane mimetic environment. A correlation was found between the conjugation induced conformational and membrane affinity changes of the INH-peptide conjugates. The degree and mode of interaction were also characterized by AFM imaging of penetrated lipid layers. In vitro biological evaluation was performed with Penetratin and Transportan conjugates. Results showed similar internalization rate into EBC-1 human squamous cell carcinoma, but markedly different subcellular localization and activity on intracellular Mtb.


Assuntos
Antituberculosos/administração & dosagem , Peptídeos Penetradores de Células/metabolismo , Portadores de Fármacos/metabolismo , Isoniazida/administração & dosagem , Lipídeos de Membrana/metabolismo , Sequência de Aminoácidos , Antituberculosos/química , Antituberculosos/farmacocinética , Linhagem Celular Tumoral , Peptídeos Penetradores de Células/química , Portadores de Fármacos/química , Humanos , Isoniazida/química , Isoniazida/farmacocinética , Bicamadas Lipídicas/metabolismo , Mycobacterium tuberculosis/efeitos dos fármacos , Tuberculose/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA